Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups

  1. Johnston, S.
  2. O’Shaughnessy, J.
  3. Martin, M.
  4. Huober, J.
  5. Toi, M.
  6. Sohn, J.
  7. André, V.A.M.
  8. Martin, H.R.
  9. Hardebeck, M.C.
  10. Goetz, M.P.
Journal:
npj Breast Cancer

ISSN: 2374-4677

Year of publication: 2021

Volume: 7

Issue: 1

Type: Article

DOI: 10.1038/S41523-021-00289-7 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals